Influence of Cardiovascular Risk Communication Tools and Presentation Formats on Patient Perceptions and Preferences
Authors:
- 1 December 2018
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Cardiology
- Vol. 3 (12) , 1192-1199
Abstract
Importance Practice guidelines recommend that clinicians engage patients in treatment decisions and explain atherosclerotic cardiovascular disease (ASCVD) risk but do not describe how to communicate this risk most effectively. Objective To determine how the ASCVD risk time horizon, outcome, and presentation format influence risk perceptions and treatment preferences. Design, Setting, and Participants From May 27, 2015, through November 12, 2015, participants from the Patient and Provider Assessment of Lipid Management Registry at 140 US cardiology, primary care, and endocrinology practices were presented 3 independent scenarios (representing the same hypothetical patient) and asked to rate their perceived risk and willingness to take medication to lower risk in light of (1) a 15% 10-year ASCVD event risk, (2) a 4% 10-year cardiovascular disease (CVD) death risk, and (3) a 50% lifetime ASCVD event risk. Exposures Participants were randomized to receive risk estimates using numbers only, a bar graph, or a face pictogram. Results Of 3566 eligible participants, 2708 (76.9%) responded (median age, 67 years [interquartile range, 61-76 years]; 280 [10.3%] African American; 1491 men [55.1%]). When shown the lifetime ASCVD risk, respondents were more likely to consider the risk “high to very high” than when presented the 10-year ASCVD risk or the CVD death risk (70.1% vs 31.4% vs 25.7%, respectively; bothP < .001). Treatment willingness was also the highest for lifetime ASCVD risk (77.9% very willing) followed by 10-year ASCVD risk (68.1%) and 10-year CVD death risk (63.1%; bothP < .001). Compared with participants who were shown a bar graph or no graphic, those who were shown the risk information with a pictogram had the lowest perception of disease severity and the lowest willingness to consider therapy. These findings were robust across demographic and socioeconomic subgroups. Conclusions and Relevance The format, time horizon, and outcome used for risk estimation influence patient perceptions and should be considered when designing risk communication tools. When shown lifetime risk estimates, patients had higher risk perception and willingness for therapy than when shown 10-year estimates. Pictogram risk displays may decrease risk perception and consideration for treatment.Keywords
This publication has 18 references indexed in Scilit:
- Design and rationale for the Patient and Provider Assessment of Lipid Management (PALM) registryAmerican Heart Journal, 2015
- Evidence-Based Risk CommunicationAnnals of Internal Medicine, 2014
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in AdultsJACC, 2014
- The Statin Choice decision aid in primary care: A randomized trialPatient Education and Counseling, 2010
- Improving lifestyle and risk perception through patient involvement in nurse-led cardiovascular risk management: A cluster-randomized controlled trial in primary carePreventive Medicine, 2010
- Patients Prefer Pictures to Numbers to Express Cardiovascular Benefit From TreatmentThe Annals of Family Medicine, 2008
- Absolute Cardiovascular Disease Risk and Shared Decision Making in Primary Care: A Randomized Controlled TrialThe Annals of Family Medicine, 2008
- Measuring Numeracy without a Math Test: Development of the Subjective Numeracy ScaleMedical Decision Making, 2007
- Presenting risk information to people with diabetes: Evaluating effects and preferences for different formats by a web-based randomised controlled trialPatient Education and Counseling, 2006
- Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in AdultsArchives of internal medicine (1960), 1988